专利检索 ap:("Pfizer Inc.") AND inv:"PIOTROWSKI, David Walter" 第 1 页

1.

发明公开
MORPHOLINE COMPOUNDS AS MINERALOCORTICOID RECEPTOR ANTAGONISTS 审中-公开
标题翻译： MORPHOLINVERBINDUGNE ALS盐皮质激素受体拮抗剂

公开(公告)号：EP2569310A1

公开(公告)日：2013-03-20

申请号：EP11723131.6

申请日：2011-04-28

申请人： Pfizer Inc.

发明人： CASIMIRO-GARCIA, Agustin , FUTATSUGI, Kentaro , PIOTROWSKI, David Walter

IPC分类号： C07D413/04 , C07D417/04 , C07D419/04 , C07D498/04 , A61K31/5377 , A61P9/12

CPC分类号： C07D498/04 , C07D413/04 , C07D417/04 , C07D419/04

摘要： Mineralocorticoid receptor antagonists (MRa), pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, diabetic nephropathy and hypertension in mammals, including humans.

2.

发明公开
PYRAZOLES AS MODULATORS OF HEMOGLOBIN 审中-公开

公开(公告)号：EP3886984A1

公开(公告)日：2021-10-06

申请号：EP19816457.6

申请日：2019-11-26

申请人： Pfizer Inc.

发明人： GOPALSAMY, Ariamala , NARAYANAN, Arjun Venkat , CASIMIRO-GARCIA, Agustin , CHOI, Chulho , HEPWORTH, David , PIOTROWSKI, David Walter , YAYLA, Hatice Gizem , JASTI, Jayasankar , ROBERTS, Lee Richard , JONES, Lyn Howard , PARIKH, Mihir Dineshkumar , CHEN, Ming Zhu , FADEYI, Olugbeminiyi Omezia , ROBINSON, JR., Ralph Pelton , DOW, Robert Lee , CABRAL, Shawn

IPC分类号： A61P7/06 , A61P35/00 , C07D401/12 , C07D401/14 , C07D405/14 , C07D413/14 , C07D471/04 , A61K31/4709 , A61K31/444 , A61K31/4375

3.

发明公开
SOLID FORMS OF 2-((4-((S)-2-(5-CHLOROPYRIDIN-2-YL)-2-METHYLBENZO[D] [1,3]DIOXOL-4-YL)PIPERIDIN-1-YL)METHYL)-1-(((S)-OXETAN-2-YL)METHYL)-1H-BENZO[D] IMIDAZOLE-6-CARBOXYLIC ACID, 1,3-DIHYDROXY-2-(HYDROXYMETHYL)PROPAN-2-AMINE SALT 审中-公开

公开(公告)号：EP4073028A1

公开(公告)日：2022-10-19

申请号：EP20824663.7

申请日：2020-12-07

申请人： Pfizer Inc.

发明人： ASPNES, Gary E. , BAGLEY, Scott W. , CLARK, Wesley Dewitt , CURTO, John M. , EDMONDS, David James , FLANAGAN, Mark E. , FUTATSUGI, Kentaro , GRIFFITH, David Andrew , HUARD, Kim , LIAN, Yajing , LIMBERAKIS, Chris , LONDREGAN, Allyn T. , MATHIOWETZ, Alan M. , PIOTROWSKI, David Walter , RUGGERI, Roger B.

IPC分类号： C07C215/12 , A61P3/00 , A61P5/00 , C07D405/14 , A61K31/4545 , A61P25/00

4.

发明公开
4, 5-DIHYDRO-1H-PYRAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL USES 审中-公开
标题翻译： 4，5-二氢-1H-吡唑及其用途HOLDER

公开(公告)号：EP2417121A1

公开(公告)日：2012-02-15

申请号：EP10714070.9

申请日：2010-03-26

申请人： Pfizer Inc.

发明人： ARHANCET, Graciela Barbieri , CASIMIRO-GARCIA, Agustin , CHEN, Xiangyang , HEPWORTH, David , MEYERS, Marvin Jay , PIOTROWSKI, David Walter , RAHEJA, Raj Kumar

IPC分类号： C07D401/04 , C07D401/14 , C07D413/14 , A61K31/44 , A61P3/04 , A61P29/00 , A61P9/00

CPC分类号： C07D401/04 , C07D401/14 , C07D413/14

摘要： Mineralocorticoid receptor antagonists (MRa), pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, diabetic nephropathy and hypertension in mammals, including humans.

5.

发明公开
COMBINATIONS COMPRISING BENZODIOXOL AS GLP-1R AGONISTS FOR USE IN THE TREATMENT OF NASH/NAFLD AND RELATED DISEASES 审中-公开

公开(公告)号：EP3972596A1

公开(公告)日：2022-03-30

申请号：EP20726962.2

申请日：2020-05-15

申请人： Pfizer Inc.

发明人： ASPNES, Gary E. , BAGLEY, Scott W. , CURTO, John M. , DOWLING, Matthew , EDMONDS, David James , FERNANDO, Dilinie , FLANAGAN, Mark E. , FUTATSUGI, Kentaro , GRIFFITH, David Andrew , HUARD, Kim , INGLE, Gajendra , JIAO, Wenhua , LACASSE, Shawn M. , LIAN, Yajing , LIMBERAKIS, Chris , LONDREGAN, Allyn T. , MATHIOWETZ, Alan M. , PIOTROWSKI, David Walter , RUGGERI, Roger B. , WIGLESWORTH, Kristin

IPC分类号： A61K31/454 , A61K31/4545 , A61K31/46 , A61K31/506 , A61P1/16 , A61P3/04 , A61P3/10 , A61K31/444 , A61K45/06